Literature DB >> 26973199

Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma.

Reiko Matsuzawa1, Keisuke Kirita2, Takeshi Kuwata3, Shigeki Umemura2, Shingo Matsumoto2, Satoshi Fujii3, Kiyotaka Yoh2, Motohiro Kojima3, Seiji Niho2, Hironobu Ohmatsu2, Atsushi Ochiai3, Masahiro Tsuboi4, Koichi Goto2, Genichiro Ishii5.   

Abstract

OBJECTIVES: Lung adenocarcinoma is heterogeneous, characterized by various histological subtypes. Determination of the predominant histological subtype (lepidic, papillary, acinar or solid-predominant) has been shown to correlate with genetic abnormalities and clinicopathological features. Although subtyping using small biopsy samples is important for tailored approaches to clinical management, limited data exist on the concordance of predominant subtype between resected specimens and biopsy specimens.
MATERIALS AND METHODS: We compared the diagnosed predominant subtypes in resected specimens and matched biopsy specimens in a series of 327 lung adenocarcinomas. The accuracy of preoperative diagnosis by biopsy and the factors that influence concordance with resected specimen analysis were examined.
RESULTS: In 211 of the 326 patients (66.0%), the predominant adenocarcinoma subtype diagnosed from biopsy matched the findings of resection analysis. Overall, the concordance rate in biopsy samples with larger tumor areas (≥ 0.7 mm(2)) was significantly higher than in those with smaller tumor area (<0.7 mm(2); 71.2% vs 60.7%, respectively; p=0.015). In the biopsy samples with smaller tumor areas, the concordance rate was 77% in lepidic subtype, 71% in papillary subtype, 60% in solid subtype, and 40% in acinar subtype. Concordance rate in the biopsy samples with larger tumor area was higher in papillary and solid subtypes (88% and 76%, respectively), but remained low in acinar subtype (37%).
CONCLUSION: The current results indicate that accuracy of adenocarcinoma subtyping based on small biopsy samples is influenced by tumor area. Our study also suggests that subtyping of acinar histology using biopsy specimen is particularly error-prone.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biopsy specimen; IASLC/ATS/ERS classification; Predominant subtype; Resected specimen

Mesh:

Year:  2016        PMID: 26973199     DOI: 10.1016/j.lungcan.2016.01.009

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma.

Authors:  Song Gao; Seth Stein; Elena N Petre; Waleed Shady; Jeremy C Durack; Carole Ridge; Prasad Adusumilli; Natasha Rekhtman; Stephen B Solomon; Etay Ziv
Journal:  Cardiovasc Intervent Radiol       Date:  2017-08-02       Impact factor: 2.740

2.  CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma.

Authors:  Ping-Chung Tsai; Yi-Chen Yeh; Po-Kuei Hsu; Chun-Ku Chen; Teh-Ying Chou; Yu-Chung Wu
Journal:  Ann Surg Oncol       Date:  2020-05-03       Impact factor: 5.344

3.  Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.

Authors:  Jonathan E Leeman; Andreas Rimner; Joseph Montecalvo; Meier Hsu; Zhigang Zhang; Donata von Reibnitz; Kelly Panchoo; Ellen Yorke; Prasad S Adusumilli; William Travis; Abraham J Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-29       Impact factor: 7.038

4.  Multivariate Analysis Of The Diagnostic Yield Of Conventional Bronchoscopy In Peripheral Lung Adenocarcinoma.

Authors:  Wei Gao; Cuiyun Li; Hui Wang; Ping Han; Yunqiang Nie
Journal:  Cancer Manag Res       Date:  2019-11-20       Impact factor: 3.989

5.  Solid histological component of adenocarcinoma might play an important role in PD-L1 expression of lung adenocarcinoma.

Authors:  Tomoyuki Miyazawa; Kei Morikawa; Kanji Otsubo; Hiroki Sakai; Hiroyuki Kimura; Motohiro Chosokabe; Naoki Furuya; Hideki Marushima; Koji Kojima; Masamichi Mineshita; Junki Koike; Hisashi Saji
Journal:  Thorac Cancer       Date:  2021-11-23       Impact factor: 3.500

6.  CT-Guided Percutaneous Core Needle Biopsy in Typing and Subtyping Lung Cancer: A Comparison to Surgery.

Authors:  Hanfei Zhang; Sufang Tian; Shan Wang; Songmei Liu; Meiyan Liao
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

7.  Predictors of Invasiveness in Adenocarcinoma of Lung with Lepidic Growth Pattern.

Authors:  Timothy J Young; Ramin Salehi-Rad; Reza Ronaghi; Jane Yanagawa; Puja Shahrouki; Bianca E Villegas; Brian Cone; Gregory A Fishbein; William D Wallace; Fereidoun Abtin; Igor Barjaktarevic
Journal:  Med Sci (Basel)       Date:  2022-06-22

8.  Thick-wall cavity predicts worse progression-free survival in lung adenocarcinoma treated with first-line EGFR-TKIs.

Authors:  Fei Zhou; Wanrong Ma; Wei Li; Huijuan Ni; Guanghui Gao; Xiaoxia Chen; Jie Zhang; Jingyun Shi
Journal:  BMC Cancer       Date:  2018-10-23       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.